NFKB1 and COVID-19: In contrast to blocking single targets of inflammatory cytokine cascade, inhibition of NF-κB pathway provides the potential to simultaneously inhibit multiple strongly pro-inflammatory cytokines and chemokines, as well as adhesion molecules increased during acute COVID-19 stages 38.